Sculptor Capital’s Allergan Inc AGN Stock Holding History

Sculptor Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-79,300	Closed	-$16.9M	–	902
2014 Q4	$16.9M	Hold	79,300	–	–	0.05%	290
2014 Q3	$14.1M	Hold	79,300	–	–	0.04%	328
2014 Q2	$13.4M	Hold	79,300	–	–	0.04%	347
2014 Q1	$9.84M	Sell	79,300 -94,100	-54%	-$11.5M	0.03%	383
2013 Q4	$19.3M	Sell	173,400 -46,700	-21%	-$4.46M	0.05%	346
2013 Q3	$19.9M	Buy	220,100 +22,600	+11%	+$2.03M	0.06%	346
2013 Q2	$16.6M	Buy	+197,500	New	+$20.5M	0.05%	351

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Sculptor Capital's AGN Position: Q1 2015 in Review

Sculptor Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 4,470,121 shares — an estimated $950M sold.

Sculptor Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $950M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Sculptor Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Sculptor Capital sold 4,470,121 Allergan Inc shares in Q1 2015, an estimated $950M.
Sculptor Capital first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Sculptor Capital's Allergan Inc position peaked at $950M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Sculptor Capital's 13F filing for Q1 2015, filed 15 May 2015.